Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (1121-1130 of 1,175) with videos related to

Pageof 118
Sort By:
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Cancers|January 11, 2025
Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate CancerBukuru Dieu-Donne Nturubika, Jessica Logan, Ian R D Johnson, et al.
JAMA|May 30, 2024
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F Newcomb, Jeannette M Schenk, Yingye Zheng, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 31, 2013
Development of a consumer product ingredient database for chemical exposure screening and prioritizationM-R Goldsmith, C M Grulke, R D Brooks, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Gut|July 17, 2008
Asia Pacific consensus recommendations for colorectal cancer screeningJ J Y Sung, J Y W Lau, G P Young, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
Pageof 118

Showing results (1121-1130 of 1,175) with videos related to

Sort By:
Pageof 118
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Cancers|January 11, 2025
Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate CancerBukuru Dieu-Donne Nturubika, Jessica Logan, Ian R D Johnson, et al.
JAMA|May 30, 2024
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F Newcomb, Jeannette M Schenk, Yingye Zheng, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 31, 2013
Development of a consumer product ingredient database for chemical exposure screening and prioritizationM-R Goldsmith, C M Grulke, R D Brooks, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Gut|July 17, 2008
Asia Pacific consensus recommendations for colorectal cancer screeningJ J Y Sung, J Y W Lau, G P Young, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
Pageof 118